| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 46,432 | 38,901 | 31,253 | 37,665 | | Cost of Revenue | 29,503 | 29,152 | 24,786 | 29,932 | | | Gross Profit | 16,929 | 9,749 | 6,467 | 7,733 | | | Operating Expenses | | Research Development | 5,646 | 4,980 | 4,186 | 5,208 | | Selling General and Administrative | 6,554 | 5,958 | 6,408 | 7,301 | | Non Recurring | (710) | 710 |
-
|
-
| | Others | 710 |
-
|
-
|
-
| | | | Total Operating Expenses | 12,200 |
-
|
-
|
-
| | | | Operating Income or Loss | 4,729 | (1,899) | (4,127) | (4,776) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 257 | (68) | 282 | 582 | | Earnings Before Interest And Taxes | 4,986 | (1,967) | (3,845) | (4,194) | | Interest Expense | 92 |
-
|
-
|
-
| | Income Before Tax | 4,894 | (1,967) | (3,845) | (4,194) | | Income Tax Expense | 34 | 50 | (42) | (60) | | Minority Interest | (88) | 91 | (23) | 64 | | | | Net Income From Continuing Ops | 4,772 | (1,926) | (3,826) | (4,070) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,772 | (1,926) | (3,826) | (4,070) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,772 | ($1,926) | ($3,826) | ($4,070) |
|
0.19% Nasdaq 
0.03%
Income Statement
